Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cholesterol
3
×
clinical trials
life sciences
national blog main
amgen
boston blog main
boston top stories
inclisiran
national top stories
new york
new york blog main
new york top stories
praluent
regeneron pharmaceuticals
repatha
the medicines co.
alnylam pharmaceuticals
bempedoic acid
biotech
corticosteroids
data
detroit
detroit blog main
detroit top stories
esperion therapeutics
ezetimibe
fda
fluoroquinolones
ldl
mark timney
mt sinai hospital
pcsk9
pcsk9 inhibitors
peter wijngaard
prashant vaishnava
san francisco blog main
san francisco top stories
sanofi
statins
tim mayleben
What
cholesterol
drug
3
×
lowering
medicines
3
×
fda
medco
twice
aces
announced
approved
big
bringing
ceo
clears
closer
combo
esperion
esperion’s
filing
flexible
inched
inclisiran
key
levels
market
meant
medicine
morning
nasdaq
nod
open
pairs
passed
phase
pill
positive
preps
pricing
regulatory
result
Language
unset
Current search:
drug
×
medicines
×
cholesterol
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing